Recombinant anti‐podoplanin (NZ‐1) immunotoxin for the treatment of malignant brain tumors

Our study demonstrates the glioma tumor antigen podoplanin to be present at very high levels (>90%) in both glioblastoma (D2159MG, D08-0308MG and D08-0493MG) and medulloblastoma (D283MED, D425MED and DAOY) xenografts and cell line. We constructed a novel recombinant single-chain antibody variable...

全面介绍

Saved in:
书目详细资料
Main Authors: Vidyalakshmi Chandramohan, Xuhui Bao, Mika K. Kaneko, Yukinari Kato, Stephen T. Keir, Scott E. Szafranski, Chien‐Tsun Kuan, Ira Pastan, Darell D. Bigner
格式: Artigo
语言:英语
出版: 2012
在线阅读:https://doi.org/10.1002/ijc.27919
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.27919
标签: 添加标签
没有标签, 成为第一个标记此记录!